Comparison of a Metal Backed Fixed-Bearing Tibial Baseplate and an All-Polyethylene Tibia in Total Knee Arthroplasty
NCT ID: NCT00979147
Last Updated: 2020-09-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
400 participants
INTERVENTIONAL
2007-11-30
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Does a MPT/XLK design have improved wear characteristics over a nonmodular APT/GVF design?
2. Is there a clear clinical advantage to the MPT/XLK design in certain patient populations that justify its use over the APT/GVF design?
Answering these questions will allow surgeons to use both designs appropriately in different demand populations.
This study is designed to address the questions of whether an MPT/XLK design offers improvement in wear characteristics, Knee Society scores, KOOS, WOMAC, SF-36, or radiographic measures, over an APT design. The investigator's primary hypothesis is that there will be no difference in these outcome measures at a minimum two year follow-up. A secondary hypothesis based on the long-term follow-up of this group, up to twenty years, is that there will be no difference in implant survival.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Primary TKA Cruciate Retaining vs Cruciate Substituting With Rotating Platform Knee Prostheses
NCT00289081
A Study to Compare the Press Fit Condylar (P.F.C.) Sigma Rotating-platform High-flexion (RP-F) Versus the Press Fit Condylar (P.F.C.) Sigma Rotating-platform (RP) Knee Implants
NCT00733369
A Study to Determine the Performance of the Press Fit Condylar (P.F.C.) Sigma RP-F Knee System
NCT00761410
A Prospective, Randomized, Controlled Study Comparing Three Tibial Component Designs in Total Knee Arthoplasty
NCT00589147
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
NCT02175576
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Modular Metal Tibial Baseplate
Patients who were randomized to receive the modular polished tibial baseplate/XLK TKA
TKA surgery with modular polished tibial baseplate/XLK design
TKA surgery with modular polished tibial baseplate/XLK design
P.F.C.® Sigma Knee System
P.F.C.® Sigma Knee System with modular XLK poly
All Polyethylene Tibial Baseplate
Patients who were randomized to receive the nonmodular APT/GVF TKA design.
TKA surgery with the nonmodular APT/GVF design
TKA surgery with the nonmodular APT/GVF design
P.F.C.® Sigma Knee System
P.F.C. ® Sigma Knee System with an all-poly GVF tibia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TKA surgery with modular polished tibial baseplate/XLK design
TKA surgery with modular polished tibial baseplate/XLK design
TKA surgery with the nonmodular APT/GVF design
TKA surgery with the nonmodular APT/GVF design
P.F.C.® Sigma Knee System
P.F.C.® Sigma Knee System with modular XLK poly
P.F.C.® Sigma Knee System
P.F.C. ® Sigma Knee System with an all-poly GVF tibia
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Routine contraindications to TKA (active sepsis, Charcot arthropathy)
* Patients whose mental function preclude them from responding to our standard questionnaires
60 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Depuy, Inc.
INDUSTRY
Minneapolis Veterans Affairs Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Terence J. Gioe, M.D.
Chief of Orthopaedic Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Terence J Gioe, M.D.
Role: PRINCIPAL_INVESTIGATOR
Minneapolis VAMC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Minneapolis VAMC
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MVA-3946B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.